TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $658,000 | +402.3% | 37,485 | +26.2% | 0.02% | +41.7% |
Q2 2017 | $131,000 | -9.7% | 29,700 | +26.4% | 0.01% | -14.3% |
Q1 2017 | $145,000 | +9.0% | 23,500 | 0.0% | 0.01% | -12.5% |
Q4 2016 | $133,000 | +2116.7% | 23,500 | +5775.0% | 0.02% | +1500.0% |
Q3 2016 | $6,000 | +200.0% | 400 | +100.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |